IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v16y2025i1d10.1038_s41467-025-58289-1.html
   My bibliography  Save this article

Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse

Author

Listed:
  • Ignacio Heras-Murillo

    (Centro Nacional de Investigaciones Cardiovasculares (CNIC))

  • Diego Mañanes

    (Centro Nacional de Investigaciones Cardiovasculares (CNIC)
    Escuela de Doctorado)

  • Pablo Munné

    (Centro Nacional de Investigaciones Cardiovasculares (CNIC))

  • Vanessa Núñez

    (Centro Nacional de Investigaciones Cardiovasculares (CNIC))

  • Jessica Herrera

    (Centro Nacional de Investigaciones Cardiovasculares (CNIC))

  • Mauro Catalá-Montoro

    (Centro Nacional de Investigaciones Cardiovasculares (CNIC))

  • Maite Alvarez

    (CIMA Universidad de Navarra)

  • Miguel A. del Pozo

    (Centro Nacional de Investigaciones Cardiovasculares (CNIC))

  • Ignacio Melero

    (CIMA Universidad de Navarra
    Navarra Institute for Health Research (IDISNA)
    Centro de Investigación Biomédica en Red de Cáncer (CIBERONC)
    Nuffield Department of Medicine and Churchill Hospital. University of Oxford)

  • Stefanie K. Wculek

    (Centro Nacional de Investigaciones Cardiovasculares (CNIC)
    The Barcelona Institute of Science and Technology (BIST))

  • David Sancho

    (Centro Nacional de Investigaciones Cardiovasculares (CNIC))

Abstract

The potential of dendritic cell (DC) vaccination against cancer is not fully achieved. Little is known about the precise nature of the anti-cancer immune response triggered by different natural DC subsets and their relevance in preventing postsurgical tumor recurrence. Here, we use mouse splenic conventional DC1s (cDC1s) or cDC2s pulsed with tumor cell lysates to generate DC vaccines. cDC1-based vaccination induces a stronger effector and memory CD4+ and CD8+ anti-tumor T cell response, leading to a better control of tumors treated either therapeutically or prophylactically. Using an experimental model of tumor relapse, we show that adjuvant or neoadjuvant cDC1 vaccination improves anti-tumor immune memory, particularly by increasing the infiltrates of CD4+ tissue resident memory (Trm) and CD8+ memory T cells. This translates into complete prevention of tumor relapses. Moreover, elevated abundance of cDC1s positively correlates with CD4+ Trm presence, and both associate with enhanced survival in human breast cancer and melanoma. Our findings suggest that cDC1-based vaccination excels at immune memory induction and prevention of cancer recurrence.

Suggested Citation

  • Ignacio Heras-Murillo & Diego Mañanes & Pablo Munné & Vanessa Núñez & Jessica Herrera & Mauro Catalá-Montoro & Maite Alvarez & Miguel A. del Pozo & Ignacio Melero & Stefanie K. Wculek & David Sancho, 2025. "Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse," Nature Communications, Nature, vol. 16(1), pages 1-17, December.
    • Handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58289-1
    DOI: 10.1038/s41467-025-58289-1
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-025-58289-1
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-025-58289-1?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Stephen T. Ferris & Vivek Durai & Renee Wu & Derek J. Theisen & Jeffrey P. Ward & Michael D. Bern & Jesse T. Davidson & Prachi Bagadia & Tiantian Liu & Carlos G. Briseño & Lijin Li & William E. Gillan, 2020. "cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity," Nature, Nature, vol. 584(7822), pages 624-629, August.
    2. Mevyn Nizard & Hélène Roussel & Mariana O. Diniz & Soumaya Karaki & Thi Tran & Thibault Voron & Estelle Dransart & Federico Sandoval & Marc Riquet & Bastien Rance & Elie Marcheteau & Elizabeth Fabre &, 2017. "Induction of resident memory T cells enhances the efficacy of cancer vaccine," Nature Communications, Nature, vol. 8(1), pages 1-11, August.
    3. Caroline Robert, 2020. "A decade of immune-checkpoint inhibitors in cancer therapy," Nature Communications, Nature, vol. 11(1), pages 1-3, December.
    4. Lei Zhang & Xin Yu & Liangtao Zheng & Yuanyuan Zhang & Yansen Li & Qiao Fang & Ranran Gao & Boxi Kang & Qiming Zhang & Julie Y. Huang & Hiroyasu Konno & Xinyi Guo & Yingjiang Ye & Songyuan Gao & Shan , 2018. "Lineage tracking reveals dynamic relationships of T cells in colorectal cancer," Nature, Nature, vol. 564(7735), pages 268-272, December.
    5. Giacomo Oliveira & Kari Stromhaug & Nicoletta Cieri & J. Bryan Iorgulescu & Susan Klaeger & Jacquelyn O. Wolff & Suzanna Rachimi & Vipheaviny Chea & Kate Krause & Samuel S. Freeman & Wandi Zhang & Shu, 2022. "Landscape of helper and regulatory antitumour CD4+ T cells in melanoma," Nature, Nature, vol. 605(7910), pages 532-538, May.
    6. Kalijn F. Bol & Gerty Schreibelt & Martine Bloemendal & Wouter W. Willigen & Simone Hins-de Bree & Anna L. Goede & Annemiek J. Boer & Kevin J. H. Bos & Tjitske Duiveman-de Boer & Michel A. M. Olde Nor, 2024. "Adjuvant dendritic cell therapy in stage IIIB/C melanoma: the MIND-DC randomized phase III trial," Nature Communications, Nature, vol. 15(1), pages 1-10, December.
    7. Damya Laoui & Jiri Keirsse & Yannick Morias & Eva Van Overmeire & Xenia Geeraerts & Yvon Elkrim & Mate Kiss & Evangelia Bolli & Qods Lahmar & Dorine Sichien & Jens Serneels & Charlotte L. Scott & Loui, 2016. "The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity," Nature Communications, Nature, vol. 7(1), pages 1-17, December.
    8. Simone L. Park & Anthony Buzzai & Jai Rautela & Jyh Liang Hor & Katharina Hochheiser & Maike Effern & Nathan McBain & Teagan Wagner & Jarem Edwards & Robyn McConville & James S. Wilmott & Richard A. S, 2019. "Author Correction: Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin," Nature, Nature, vol. 566(7745), pages 10-10, February.
    9. Michel Enamorado & Salvador Iborra & Elena Priego & Francisco J. Cueto & Juan A. Quintana & Sarai Martínez-Cano & Ernesto Mejías-Pérez & Mariano Esteban & Ignacio Melero & Andrés Hidalgo & David Sanch, 2017. "Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells," Nature Communications, Nature, vol. 8(1), pages 1-11, December.
    10. Simone L. Park & Anthony Buzzai & Jai Rautela & Jyh Liang Hor & Katharina Hochheiser & Maike Effern & Nathan McBain & Teagan Wagner & Jarem Edwards & Robyn McConville & James S. Wilmott & Richard A. S, 2019. "Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin," Nature, Nature, vol. 565(7739), pages 366-371, January.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Guo Li & Saranya Srinivasan & Liwen Wang & Chaoyu Ma & Kai Guo & Wenhao Xiao & Wei Liao & Shruti Mishra & Xin Zhang & Yuanzheng Qiu & Qianjin Lu & Yong Liu & Nu Zhang, 2022. "TGF-β-dependent lymphoid tissue residency of stem-like T cells limits response to tumor vaccine," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    2. Qingnan Zhao & Jiemiao Hu & Lingyuan Kong & Shan Jiang & Xiangjun Tian & Jing Wang & Rintaro Hashizume & Zhiliang Jia & Natalie Wall Fowlkes & Jun Yan & Xueqing Xia & Sofia F. Yi & Long Hoang Dao & Da, 2023. "FGL2-targeting T cells exhibit antitumor effects on glioblastoma and recruit tumor-specific brain-resident memory T cells," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    3. Curtis J. Pritzl & Dezzarae Luera & Karin M. Knudson & Michael J. Quaney & Michael J. Calcutt & Mark A. Daniels & Emma Teixeiro, 2023. "IKK2/NFkB signaling controls lung resident CD8+ T cell memory during influenza infection," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    4. Denise Lau & Sonal Khare & Michelle M. Stein & Prerna Jain & Yinjie Gao & Aicha BenTaieb & Tim A. Rand & Ameen A. Salahudeen & Aly A. Khan, 2022. "Integration of tumor extrinsic and intrinsic features associates with immunotherapy response in non-small cell lung cancer," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    5. Nekisa Zakeri & Andrew Hall & Leo Swadling & Laura J. Pallett & Nathalie M. Schmidt & Mariana O. Diniz & Stephanie Kucykowicz & Oliver E. Amin & Amir Gander & Massimo Pinzani & Brian R. Davidson & Alb, 2022. "Characterisation and induction of tissue-resident gamma delta T-cells to target hepatocellular carcinoma," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    6. Yanchuan Li & Huamei Li & Cheng Peng & Ge Meng & Yijun Lu & Honglin Liu & Li Cui & Huan Zhou & Zhu Xu & Lingyun Sun & Lihong Liu & Qing Xiong & Beicheng Sun & Shiping Jiao, 2024. "Unraveling the spatial organization and development of human thymocytes through integration of spatial transcriptomics and single-cell multi-omics profiling," Nature Communications, Nature, vol. 15(1), pages 1-25, December.
    7. Keyong Sun & Runda Xu & Fuhai Ma & Naixue Yang & Yang Li & Xiaofeng Sun & Peng Jin & Wenzhe Kang & Lemei Jia & Jianping Xiong & Haitao Hu & Yantao Tian & Xun Lan, 2022. "scRNA-seq of gastric tumor shows complex intercellular interaction with an alternative T cell exhaustion trajectory," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    8. Yue Wang & Shi-Kun Zhou & Yan Wang & Zi-Dong Lu & Yue Zhang & Cong-Fei Xu & Jun Wang, 2023. "Engineering tumor-specific gene nanomedicine to recruit and activate T cells for enhanced immunotherapy," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    9. Weili Ma & Maria Cecília Oliveira-Nunes & Ke Xu & Andrew Kossenkov & Benjamin C. Reiner & Richard C. Crist & James Hayden & Qing Chen, 2023. "Type I interferon response in astrocytes promotes brain metastasis by enhancing monocytic myeloid cell recruitment," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    10. Handong Sun & Lishen Zhang & Zhonglin Wang & Danling Gu & Mengyan Zhu & Yun Cai & Lu Li & Jiaqi Tang & Bin Huang & Bakwatanisa Bosco & Ning Li & Lingxiang Wu & Wei Wu & Liangyu Li & Yuan Liang & Lin L, 2023. "Single-cell transcriptome analysis indicates fatty acid metabolism-mediated metastasis and immunosuppression in male breast cancer," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    11. Livius Penter & Mehdi Borji & Adi Nagler & Haoxiang Lyu & Wesley S. Lu & Nicoletta Cieri & Katie Maurer & Giacomo Oliveira & Aziz M. Al’Khafaji & Kiran V. Garimella & Shuqiang Li & Donna S. Neuberg & , 2024. "Integrative genotyping of cancer and immune phenotypes by long-read sequencing," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    12. Sumin Jo & Shipra Das & Alan Williams & Anne-Sophie Chretien & Thomas Pagliardini & Aude Roy & Jorge Postigo Fernandez & Diane Clerre & Billal Jahangiri & Isabelle Chion-Sotinel & Sandra Rozlan & Emil, 2022. "Endowing universal CAR T-cell with immune-evasive properties using TALEN-gene editing," Nature Communications, Nature, vol. 13(1), pages 1-16, December.
    13. Lucía López & Luciano Gastón Morosi & Federica Terza & Pierre Bourdely & Giuseppe Rospo & Roberto Amadio & Giulia Maria Piperno & Valentina Russo & Camilla Volponi & Simone Vodret & Sonal Joshi & Fran, 2024. "Dendritic cell-targeted therapy expands CD8 T cell responses to bona-fide neoantigens in lung tumors," Nature Communications, Nature, vol. 15(1), pages 1-17, December.
    14. Shiyu Zuo & Chuo Li & Xiaolei Sun & Biping Deng & Yibing Zhang & Yajing Han & Zhuojun Ling & Jinlong Xu & Jiajia Duan & Zelin Wang & Xinjian Yu & Qinlong Zheng & Xiuwen Xu & Jiao Zong & Zhenglong Tian, 2024. "C-JUN overexpressing CAR-T cells in acute myeloid leukemia: preclinical characterization and phase I trial," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    15. Carolina Alves Costa Silva & Gianmarco Piccinno & Déborah Suissa & Mélanie Bourgin & Gerty Schreibelt & Sylvère Durand & Roxanne Birebent & Marine Fidelle & Cissé Sow & Fanny Aprahamian & Paolo Manghi, 2024. "Influence of microbiota-associated metabolic reprogramming on clinical outcome in patients with melanoma from the randomized adjuvant dendritic cell-based MIND-DC trial," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    16. Hao Li & Meng-Jie Zhang & Boxin Zhang & Wen-Ping Lin & Shu-Jin Li & Dian Xiong & Qing Wang & Wen-Da Wang & Qi-Chao Yang & Cong-Fa Huang & Wei-Wei Deng & Zhi-Jun Sun, 2025. "Mature tertiary lymphoid structures evoke intra-tumoral T and B cell responses via progenitor exhausted CD4+ T cells in head and neck cancer," Nature Communications, Nature, vol. 16(1), pages 1-20, December.
    17. Yang Liu & Shuang-Yan Ye & Shuai He & Dong-Mei Chi & Xiu-Zhi Wang & Yue-Feng Wen & Dong Ma & Run-Cong Nie & Pu Xiang & You Zhou & Zhao-Hui Ruan & Rou-Jun Peng & Chun-Ling Luo & Pan-Pan Wei & Guo-Wang , 2024. "Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
    18. Samar Elorbany & Chiara Berlato & Larissa S. Carnevalli & Eleni Maniati & Simon T. Barry & Jun Wang & Ranjit Manchanda & Julia Kzhyshkowska & Frances Balkwill, 2024. "Immunotherapy that improves response to chemotherapy in high-grade serous ovarian cancer," Nature Communications, Nature, vol. 15(1), pages 1-20, December.
    19. Diego Calzada-Fraile & Salvador Iborra & Marta Ramírez-Huesca & Inmaculada Jorge & Enrico Dotta & Elena Hernández-García & Noa Martín-Cófreces & Estanislao Nistal-Villán & Esteban Veiga & Jesús Vázque, 2023. "Immune synapse formation promotes lipid peroxidation and MHC-I upregulation in licensed dendritic cells for efficient priming of CD8+ T cells," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    20. Sarah Cappuyns & Gino Philips & Vincent Vandecaveye & Bram Boeckx & Rogier Schepers & Thomas Van Brussel & Ingrid Arijs & Aurelie Mechels & Ayse Bassez & Francesca Lodi & Joris Jaekers & Halit Topal &, 2023. "PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma," Nature Communications, Nature, vol. 14(1), pages 1-17, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-58289-1. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.